|
Acute Communicable Disease Control
|
County of Los Angeles
Department of Public Health
Acute Communicable Disease Control
313 N. Figueroa Street, Room 212
Los Angeles, CA 90012
Phone: (213) 240-7941
Fax: (213) 482-4856
E-Mail: acdc2@ph.lacounty.gov
|
|
Call 211 For Information 24/7 |

Have questions about things like where to go for vaccinations or
other health care
services?
Call 2-1-1.
|

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. If you are using an earlier version of Adobe Acrobat Reader (4.x or less), document functionality may be reduced.
|
|
|
Acute Communicable Disease Control
|
Preventing and Controlling Antibiotic Resistance
Reference Journal Articles (Statistics & Trends)
By Topic
Statistics & Trends
Albrich WC, Monnet DL, Harbarth S. Antibiotic Selection Pressure
and Resistance in Streptococcus pneumoniae and Streptococcus
pyogenes. Emerg Infect Dis, Vol 10, No. 3, 2004
Cantrell R, Young AF, Martin BC. Antibiotic prescribing in
ambulatory care settings for adults with colds, upper
respiratory tract infections, and bronchitis. Clin Ther. 2002
Jan;24(1):170-82.
Ciesla G, Leader S, Stoddard J. Antibiotic prescribing rates in
the US ambulatory care setting for patients diagnosed with
influenza, 1997-2001. Respir Med. 2004 Nov;98(11):1093-101.
McCaig LF, Besser RE, Hughes JM. Antimicrobial-drug prescrption
in ambulatory care settings, United States, 1992-2000. Emerg
Infect Dis, Vol 9, No. 3, 2003
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM,
Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D,
Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core
Surveillance of the Emerging Infections Program Network. Decline
in invasive pneumococcal disease after the introduction of
protein-polysaccharide conjugate vaccine. N Engl J Med. 2003 May
1;348(18):1737-46.
Back to Top
Back to Preventing and Controlling Antibiotic Resistance
|
|